| Literature DB >> 27589511 |
Hiroshi Moriyama1, Shogo Hayashi2, Yuriko Inoue1, Masahiro Itoh2, Naruhito Otsuka1.
Abstract
BACKGROUND: The elucidation of the relationship between the morphology of the peripheral nerves and the diseases would be valuable in developing new medical treatments on the assumption that characteristics of the peripheral nerves in females are different from those in males.Entities:
Keywords: Peripheral nerve; axon; human; morphometry; neurological disorder; sex difference
Mesh:
Year: 2016 PMID: 27589511 PMCID: PMC5008230 DOI: 10.3233/NRE-161372
Source DB: PubMed Journal: NeuroRehabilitation ISSN: 1053-8135 Impact factor: 2.138
Fig.1A low-power view of the inferior alveolar nerve from a 78-year-old man, modified luxol fast blue-periodic acid Schiff-hematoxylin triple stain. Scale bar = 100 μm.
Fig.2A high-power view of the inferior alveolar nerve from a 68-year-old man, modified luxol fast blue-periodic acid Schiff-hematoxylin triple stain. Axons were stained dark purple or black, and surrounded by a myelin sheath stained indigo blue. Scale bar = 50 μm.
Comparison of myelinated axons in the peripheral nerves between females and males
| Nerve | Sex | Number of Specimens | Total Number or Number/Unit area | Average Transverse Area (μm2) | Average Circularity Ratio |
| Oculomotor | F | 10 | 18,305±3,669 | 6.14±1.09 | 0.83±0.04 |
| M | 10 | 19,640±4,996 | 6.39±1.18 | 0.85±0.03 | |
| 95% CI | –2,784 to 5,452 | –0.82 to 1.32 | –0.01 to 0.06 | ||
| Ophthalmic | F | 10 | 32 ± 9 (16 × 16 μm2) | 4.16 ± 1.64 | 0.84 ± 0.04 |
| M | 10 | 37 ± 9 (16 × 16 μm2) | 5.18 ± 1.10 | 0.86 ± 0.05 | |
| 95% CI | –4 to 13 | –0.29 to 2.33 | –0.02 to 0.06 | ||
| Inferior Alveolar | F | 10 | 21,910 ± 8,128 | 33.60 ± 8.29 | 0.87 ± 0.03 |
| M | 10 | 23,633 ± 7,046 | 30.83 ± 9.23 | 0.86 ± 0.05 | |
| 95% CI | –5,423 to 8,869 | –11.01 to 5.47 | –0.05 to 0.03 | ||
| Abducent | F | 10 | 1,861 ± 360 | 4.13 ± 0.58 | 0.79 ± 0.08 |
| M | 10 | 2,110 ± 506 | 3.98 ± 0.47 | 0.77 ± 0.05 | |
| 95% CI | –164 to 660 | –0.65 to 0.35 | –0.09 to 0.04 | ||
| Facial | F | 10 | 6,157 ± 579 | 6.64 ± 0.83 | 0.80 ± 0.07 |
| M | 10 | 6,567 ± 738 | 6.25 ± 0.69 | 0.79 ± 0.06 | |
| 95% CI | –213 to 1,033 | –1.10 to 0.33 | –0.07 to 0.05 | ||
| Vestibular | F | 10 | 18,488 ± 2,725* | 3.64 ± 0.56 | 0.88 ± 0.04 |
| M | 10 | 22,321 ± 3,448* | 3.60 ± 1.01 | 0.86 ± 0.08 | |
| 95% CI | 914 to 6,753 | –0.81 to 0.73 | –0.08 to 0.04 | ||
| Cochlear | F | 10 | 23,183 ± 4,192 | 1.80 ± 0.30 | 0.86 ± 0.02 |
| M | 10 | 25,937 ± 5,234 | 1.83 ± 0.24 | 0.85 ± 0.02 | |
| 95% CI | –1,701 to 7,209 | –0.23 to 0.29 | –0.03 to 0.01 | ||
| Vagus | F | 10 | 1,456 ± 315 | 1.10 ± 0.27 | 0.79 ± 0.06* |
| M | 10 | 1,320 ± 209 | 1.27 ± 0.32 | 0.85 ± 0.04* | |
| 95% CI | –388 to 115 | –0.11 to 0.45 | 0.01 to 0.11 | ||
| Recurrent Laryngeal | F | 10 | 14 ± 2/33 × 33 μm2 | 10.31 ± 2.16 | 0.87 ± 0.04 |
| M | 10 | 15 ± 3/33 × 33 μm2 | 10.68 ± 1.98 | 0.90 ± 0.04 | |
| 95% CI | –1 to 3 | –1.58 to 2.32 | –0.01 to 0.06 | ||
| Femoral | F | 10 | 28 ± 12/33 × 33 μm2 | 5.62 ± 1.56 | 0.90 ± 0.07 |
| M | 10 | 32 ± 11/33 × 33 μm2 | 6.19 ± 1.68 | 0.91 ± 0.05 | |
| 95% CI | –7 to 15 | –0.96 to 2.09 | –0.05 to 0.07 | ||
| Tibial | F | 10 | 1,389 ± 468 | 2.64 ± 0.42 | 0.93 ± 0.04 |
| M | 10 | 1,550 ± 573 | 2.95 ± 0.40 | 0.91 ± 0.07 | |
| 95% CI | –330 to 653 | –0.08 to 0.70 | –0.07 to 0.03 | ||
| Greater Splanchnic | F | 10 | 9 ± 2/16 × 16 μm2 | 5.58 ± 1.38 | 0.86 ± 0.07 |
| M | 10 | 8 ± 2/16 × 16 μm2 | 5.81 ± 0.74 | 0.88 ± 0.07 | |
| 95% CI | –3 to 1 | –0.81 to 1.28 | –0.05 to 0.08 | ||
| Lesser Splanchnic | F | 10 | 12 ± 6/16 × 16 μm2 | 1.63 ± 0.96 | 0.85 ± 0.10 |
| M | 10 | 12 ± 4/16 × 16 μm2 | 1.66 ± 0.66 | 0.83 ± 0.12 | |
| 95% CI | –4 to 5 | –0.75 to 0.80 | –0.12 to 0.09 |
*Indicates a significant difference (p < 0.05). Each value is the mean ± SD. CI, confidence interval.